Corteva, Inc.(CTVA)

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Latest News & Analysis
Corteva Q3 Results Confirm Separation Thesis, Raises 2025 Guidance and Offers 2026 View
[CTVA](/dashboard/companies/CTVA) Q3 results beat expectations, raising FY25 guidance and providing first 2026 outlook as separation timeline stays on track.
Corteva Q3 Preview Validates Separation Thesis as Seed Soars, Crop Protection Struggles
[CTVA](/dashboard/companies/CTVA) Q3 preview shows seed revenue up 30.5% while crop protection EBITDA falls 6.9%, validating separation thesis.
Corteva Q4 2024 Earnings: A Deep Dive into Sustainable Agriculture and Market Outlook
An in-depth analysis of Corteva’s mixed Q4 results, strategic investments, and market dynamics shaping sustainable agriculture.
Corteva's Q4 2024 Earnings: A Strategic Outlook for the Agricultural Giant
Corteva faces mixed signals amid analyst upgrades, strategic bio-insecticide investments, and currency fluctuation concerns. Key insights for investors and analysts.
Corteva's Market Impact: Analyzing Financial Performance
Corteva faces mixed analyst sentiment amid strategic shifts, currency headwinds, and Brazil's growth sustainability. A comprehensive update on CTVA's market dynamics and future prospects.
Corteva Inc.: Navigating Market Dynamics and Industry Trends in 2025
Corteva, Inc. (CTVA) faces mixed Q4 earnings, strategic bioinsecticide investments, and currency challenges amid strong Brazil performance.
Corteva (CTVA): Strategic Outlook, Analyst Forecasts, and Sustainable Agriculture Investments
Corteva faces a mixed outlook with strong volume growth offset by currency headwinds. Strategic investments in sustainable agriculture signal long-term growth.
Corteva (CTVA) Q4 Earnings: Brazil Growth, Bioinsecticides, and Market Outlook
Corteva's Q4 2024 reveals mixed results, Brazil's growth, bioinsecticide investments, and analyst forecasts shape market outlook. Currency headwinds and CEO stock sales impact CTVA.
Corteva: Bioinsecticide Investment & Currency Challenges
Corteva navigates currency headwinds while strategically investing in bioinsecticides. Analyst forecasts are mixed, and a Bank of America conference participation looms.
Corteva, Inc. News: Navigating Market Dynamics and Investments
Corteva, Inc. navigates a dynamic market with analyst upgrades, currency headwinds, and strategic investments shaping its trajectory. A comprehensive analysis follows.
Corteva (CTVA): R&D, Bioinsecticides, and Market Impact Analysis
Analysis of Corteva's R&D investments, bioinsecticide strategy, earnings, and market performance. Insights into future outlook and potential challenges.
Corteva (CTVA) Q1 2025 Earnings Preview: R&D and Market Outlook
A comprehensive analysis of Corteva's Q1 2025 earnings preview, R&D investments, market position, and the impact of commodity prices and regulatory factors.
Corteva (CTVA) Financial Analysis: Earnings, R&D, and Market Outlook
Corteva (CTVA) faces a shifting agricultural market. We analyze recent financials, R&D focus, and strategic moves ahead of Q1 2025 earnings.
Corteva (CTVA): Biocontrol Innovation and Financial Outlook
Corteva's strategic investments in biocontrols, leveraging peptide technology and microbial solutions, position it for long-term growth despite recent stock dip.
Corteva, Inc. Comprehensive Market Update: Innovation, Financial Discipline, and Sustainable Growth
Explore Corteva's latest strategic moves in biologicals and R&D, strong Q1 2025 financials, and leadership in sustainable agriculture shaping future investor value.
Corteva, Inc. Financial Update and Biocontrol Innovation Driving Sustainable Growth
Corteva's strategic biocontrol investments and solid Q1 2025 financials highlight its leadership in sustainable agriculture and growth in biologicals market.
Corteva, Inc. (CTVA) Strategic Growth in Biofuels and Sustainable Agriculture Amid Brazil’s Policy Shift
Corteva leverages Brazil's aggressive biofuel mandates and biotech innovations to drive growth, backed by strong financial metrics and strategic investments.
Corteva, Inc. Q2 2025 Analysis: Brazil Biofuel Policy Spurs Growth Amid Operational Efficiency
Corteva's Q2 earnings poised for growth driven by Brazil's biofuel policy, operational cost savings, and new product launches, supporting margin expansion and strategic positioning.
Corteva Inc. Strategic Growth in Biofuels and Sustainable Agriculture - Monexa AI Analysis
Corteva leverages Brazil's E30 ethanol mandate and biocontrol innovations to drive growth, margin expansion, and analyst confidence in sustainable agriculture.
Corteva (CTVA) Analysis: Q2 Outlook, Debt Strategy, and Trade Impact
Corteva's strategic moves, including recent debt refinancing and navigating complex trade policies, set the stage for its upcoming Q2 2025 earnings.
Corteva, Inc. Q2 2025 Earnings Insight: Strategic Growth Amid Brazil Biofuel Policy Impact
Corteva's Q2 2025 earnings preview highlights growth from Brazil's biofuel policy, innovation in seeds and crop protection, and robust financial fundamentals.
Corteva Inc. Q2 2025 Analysis: Earnings Beat, Growth Drivers, and Strategic Outlook
Corteva Inc. (CTVA) beats Q2 2025 earnings estimates, driven by seed and crop protection growth, strategic capital allocation, and a raised full-year outlook.
Corteva (CTVA) — Q2 Beats, Upgraded 2025 Guidance and Cash Returns: What the Numbers Really Mean
Corteva reported a Q2 2025 EPS beat of +16.38% and raised full‑year guidance; strong seed margins, LatAm crop‑protection volumes, improved free cash flow and a manageable PFAS allocation shape the investment case.
Corteva Unveils Historic Separation into Two Agricultural Giants
[CTVA](/dashboard/companies/CTVA) to split into two independent agricultural companies, separating seed and crop protection by late 2026.